1Vincennti F, Lantz M, Bimbaum J, et al. A phase I trial of humanized anti-interleukin 2 receptor antibody in renal transplantation. Trans-plantation, 1997,63: 33-38.
2Nashan B, Light S, Hardie IR, et al. Reduction of acute renal allograft rejection by daclizumab. Transplantation, 1999,67:110- 115.
3Vincenti F, Kirkman R, Light S, et al. Intcrleukin-2 receptor blockade with daclizumab to prevent acute rejection in renal transplantation. N Engl J Med,1998,338:161-165.
